ASG. Aurora Spine Corp

Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office

Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
EN
05/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aurora Spine Corp

 PRESS RELEASE

Aurora Spine Launches New Biologics Portfolio

Aurora Spine Launches New Biologics Portfolio New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of Aurora Biologics creates seamless synergy across Aurora’s gr...

 PRESS RELEASE

Aurora Spine Announces Proposed Warrant Extension

Aurora Spine Announces Proposed Warrant Extension CARLSBAD, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces that, subject to the approval of the TSX Venture Exchange,  it is proposing to amend the terms of an aggregate of 6,445,939 common share purchase warrants (the “Warrants”) by extending the expiry date of the Warrants until October 15, 2026. The Warrants, with an exercise price of CDN$0.50 and an original expiry...

 PRESS RELEASE

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody...

Aurora Spine Announces Launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device CARLSBAD, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces the official launch of its DEXA-L™ Anterior Lumbar Interbody Fusion Device, with the product being implanted in recent initial surgeries. DEXA-L is part of Aurora’s patented DEXA™ Technology Platform, which is a series of products that are the world’s first bone density ...

 PRESS RELEASE

Aurora Spine Corporation Announces Record Second Quarter Financial Re...

Aurora Spine Corporation Announces Record Second Quarter Financial Results  - Company to host conference call Tuesday, September 2nd at 11am ET/8am PT -  NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for second quarter ended June 30, 2025. All figures are in U.S. dollars. Significant ...

 PRESS RELEASE

Aurora Spine Announces Participation in 7th Annual American Society of...

Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference CARLSBAD, California, July 15, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announced it will be participating in the 7th Annual ASPN Conference sponsored by The American Society of Pain Neuroscience (ASPN) to be held July 17-20 at the Fontainebleu Miami Hotel in Miami Beach, Florida. Aurora will be located at Booth 129/130.To kick off the fir...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch